Summary
It was examined whether genetic factors are involved in the expression of alpha-2 adrenergic receptors on human platelets, as measured with 3H-yohimbine as ligand. The twin series comprised 17 monozygotic and 15 dizygotic adult, healthy, male, drug-free twin pairs. For control of intraindividual and interassay variation, 13 unrelated pairs of subjects were examined. Bmax values for 3H-yohimbine binding (range 91–305 fmol/mg protein) proved to be under considerable genetic control; this was not the case for KD values. Different possible genetic mechanisms are discussed.
Similar content being viewed by others
References
Brodde OE, Anlauf M, Graben N, Bock KD (1982) Age-dependent decrease of alpha-adrenergic receptor number in human platelets. Eur J Pharmacol 81:345–347
Brown MS, Goldstein JL (1976) Familial hypercholesterolemia: a genetic defect in the low-density lipoprotein receptor. N Engl J Med 294:1386–1390
Davies IB, Mathias CJ, Sudera D, Sever PS (1982) Agonist regulation of alpha-adrenergic receptor responses in man. J Cardiovasc Pharmacol 4 (Suppl 1):S139-S144
Friedl W, Propping P, Weck B (1983) 3H-Imipramine binding in platelets: influence of varying proportions of intact platelets in membrane preparations on binding. Psychopharmacology 80:96–99
Griffin JE, Wilson JD (1980) The syndromes of androgen resistance. N Engl J Med 302:198–209
Jakobs KH (1978) Synthetic alpha-adrenergic agonists are potent alpha-adrenergic blockers in human platelets. Nature 274:819–820
Maartmann-Moe K, Magnus P, Golden W, Berg K (1981) Genetics of the low density lipoprotein receptor: III. Evidence for multiple normal alleles at the low density lipoprotein receptor locus. Clin Genet 20:113–129
Magnus P, Maartmann-Moe K, Golden W, Nance WE, Berg K (1981) Genetics of the low density lipoprotein receptor: II. Genetic control of variation in cell membrane low density lipoprotein receptor activity in cultured fibroblasts. Clin Genet 20:104–112
Motulsky HJ, Insel PA (1982) Adrenergic receptors in man. Direct identification, physiologic regulation, and clinical alterations. N Engl J Med 307:18–29
Motulsky HJ, Shattil SJ, Insel PA (1980) Characterization of alpha2-adrenergic receptors on human platelets using 3H-yohimbine. Biochem Biophys Res Commun 97:1562–1570
Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83: 346–356
Propping P (1977) Genetic control of ethanol action on the central nervous system. An EEG study in twins. Hum Genet 35:309–334
Rüdiger HW, Dreyer M (1983) Pathogenetic mechanisms of hereditary diabetes mellitus. Hum Genet 63:100–106
Schultz G, Aktories K, Böhme E, Gerzer R, Jakobs KH (1982) Signal transformation mediated by membrane receptors for hormones and neurotransmitters. Mol Immunol 19:1207–1214
Vogel F, Motulsky AG (1979) Human genetics. Problems and approaches. Springer, Berlin Heidelberg New York
Author information
Authors and Affiliations
Additional information
Supported by Deutsche Forschungsgemeinschaft
Rights and permissions
About this article
Cite this article
Propping, P., Friedl, W. Genetic control of adrenergic receptors on human platelets. A twin study. Hum Genet 64, 105–109 (1983). https://doi.org/10.1007/BF00327103
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00327103